Vimarsana
Biggest News Aggregation in the World

Page 21 - Study App News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study App. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study App Today - Breaking & Trending Today

Your guide to side-effects: What you can expect after a Covid-19 jab - Vimarsana News

Your guide to side-effects: What you can expect after a Covid-19 jab

But how will the Pfizer and J&J shots affect you - can you, for instance, expect any side-effects? The Sisonke trial, which uses the J&J jab, was, for example, recently paused for two weeks to investigate reports about rare blood clots linked to the vaccine. So how do you know if a side-effect is something to be concerned about and how often are such symptoms likely to occur? We break it down. 1. What is a side-effect? To answer that, let’s take a quick refresher on how vaccines work. (A great place to start is to watch the first session of the Vaccine Science 101 course Bhekisisa and the ...

Source: news24.com
Study on side effects of COVID-19 vaccines - Vimarsana News

Study on side effects of COVID-19 vaccines

An investigation conducted by analysts at King College London tracked down that one out of four individuals experience mild, short-lived systemic side effects

Smoking is Associated With Increased Risk of COVID-19 - Vimarsana News

Smoking is Associated With Increased Risk of COVID-19

Smoking was associated with not only a greater risk of disease, but also an increased risk of severe COVID-19.&nbsp;<br /> <br /> &nbsp;

COVID-19 Scan for Jan 06, 2021 - Vimarsana News

COVID-19 Scan for Jan 06, 2021

In a US study published today in Science, researchers detected immune memory to SARS-CoV-2 across all immune cell types studied for as long as 8 months after patients became ill with COVID-19. In the study, a team led by researchers from the La Jolla Institute for Immunology in California analyzed levels of antibodies and other cells involved in immune response to the novel coronavirus in 254 specimens from 188 recovered adult COVID-19 patients, including 43 samples taken 6 months or more after infection. Recruited from sites across the United States, study participants had a range of COVID-...

Source: umn.edu